Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Using IIoT-Connected Devices for Worker Health & Safety March 29, 2019 Axiomtek introduces IPC964- 512-F industrial embedded PC April 4, 2018 Toposens announces release of TS3 ultrasonic sensor July 11, 2019